Moreover, a direct correlation between the amount of 2HG produced by mutant IDH1/2 and the characteristics of the resulting tumor seems to exist, since patients with IDH2 R140-mutant AML produce lower levels of D-2HG and have a better prognosis those with IDH2 R172 mutations [19]. The gene discussed is IDH2; the disease is acute myeloid leukemia.